Long-acting inhaled bronchodilators for cystic fibrosis
Author:
Affiliation:
1. Division of Child Health, Obstetrics & Gynaecology (COG), School of Medicine; University of Nottingham; Nottingham UK
2. Leeds Regional Paediatric Respiratory & Cystic Fibrosis Centre; A Floor, Clarendon Wing, Leeds Children's Hospital; Leeds UK
Publisher
Wiley
Subject
Pharmacology (medical)
Reference68 articles.
1. Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results;Bradley;PloS One,2014
2. A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 µg and 5 µg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis;Elborn;Journal of Cystic Fibrosis,2011
3. Tiotropium in cystic fibrosis: pooled analysis of phase II and III randomized controlled trials;Geller;Journal of Cystic Fibrosis,2013
4. Safety and efficacy of 12-wk treatment with two doses of tiotropium respimat in cystic fibrosis Clinicaltrials.gov/ct2/show/NCT00737100
5. Tiotropium Respimat® in cystic fibrosis: phase 3 and pooled phase 2/3 randomized trials;Ratjen;Journal of Cystic Fibrosis,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa;Pneumologie;2024-02-13
2. Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis;Revista Paulista de Pediatria;2024
3. Breath of fresh insight: unraveling the evolution of our understanding of cystic fibrosis pulmonary exacerbations;Current Opinion in Pulmonary Medicine;2023-08-29
4. Aerosol pulmonary immune engineering;Advanced Drug Delivery Reviews;2023-08
5. Short-acting inhaled bronchodilators for cystic fibrosis;Cochrane Database of Systematic Reviews;2022-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3